Regional thermochemotherapy versus hepatic arterial infusion chemotherapy for palliative treatment of advanced hilar cholangiocarcinoma: a retrospective controlled study

被引：0
|
作者：
Yaoting Chen
Huiqing Li
Xiongying Jiang
Dong Chen
Jiayan Ni
Hongliang Sun
Jianghong Luo
Herui Yao
Linfeng Xu
机构：
[1] Sun Yat-sen University,Department of Interventional Radiology, Sun Yat
[2] Sun Yat-Sen Memorial Hospital,sen Memorial Hospital
[3] Sun Yat-Sen University,Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation
[4] Sun Yat-sen University,Health Center, Sun Yat
[5] Sun Yat-sen University,sen Memorial Hospital
来源：
European Radiology | 2016年 / 26卷
关键词：
Hilar cholangiocarcinoma; Thermochemotherapy; Treatment; Efficacy; Prognostic factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3500 / 3509
页数：9
相关论文
共 28 条
  • [21] A Phase I Study of Locoregional High-Dose Autologous Natural Killer Cell Therapy With Hepatic Arterial Infusion Chemotherapy in Patients With Locally Advanced Hepatocellular Carcinoma
    Bae, Woo Kyun
    Lee, Byung Chan
    Kim, Hyeon-Jong
    Lee, Je-Jung
    Chung, Ik-Joo
    Cho, Sung Bum
    Koh, Yang Seok
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [22] PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study
    Wang, Dazhen
    Zhang, Zhengfeng
    Yang, Liu
    Zhao, Lu
    Liu, Ze
    Lou, Changjie
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1157 - 1170
  • [23] Pembrolizumab plus lenvatinib with or without hepatic arterial infusion chemotherapy in selected populations of patients with treatment-naive unresectable hepatocellular carcinoma exhibiting PD-L1 staining: a multicenter retrospective study
    Chen, Song
    Xu, Bo
    Wu, Zhiqiang
    Wang, Pengfei
    Yu, Weiguang
    Liu, Zhiyong
    Huang, Xiaoyong
    Wu, Yanqing
    Li, Tengfei
    Guo, Wenbo
    BMC CANCER, 2021, 21 (01)
  • [24] Efficiency and safety of hepatic arterial infusion chemotherapy (HAIC) combined with anti-PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis
    Li, Yangyang
    Liu, Wendao
    Chen, Junwei
    Chen, Yongxin
    Guo, Jiandong
    Pang, Huajin
    Zhang, Wentao
    An, Chao
    Li, Chengzhi
    CANCER MEDICINE, 2024, 13 (01):
  • [25] Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study
    Liu, Guanxiong
    Zhu, Duo
    He, Quansheng
    Zhou, Churen
    He, Li
    Li, Zhengran
    Jiang, Zaibo
    Huang, Mingsheng
    Chang, Boyang
    Wu, Chun
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1415 - 1428
  • [26] PD-1 inhibitor versus bevacizumab in combination with platinum-based chemotherapy for first-line treatment of advanced lung adenocarcinoma: A retrospective-real world study
    Huang, Zhe
    Zhou, Chunhua
    Xiong, Yi
    Yang, Feng
    Zeng, Fanxu
    Jiang, Wenjuan
    Zhang, Yongchang
    Yang, Haiyan
    Liu, Li
    Zeng, Liang
    Yang, Nong
    Wang, Zhan
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Almonertinib plus chemotherapy versus almonertinib alone in second-line treatment of advanced non-small cell lung cancer with mutated epidermal growth factor receptor: a retrospective study
    Fang, Xiaoxu
    Xiang, Yan
    Lu, Kaihua
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] Intrapleural infusion of tumor cell-derived microparticles packaging methotrexate or saline combined with pemetrexed-cisplatin chemotherapy for the treatment of malignant pleural effusion in advanced non-squamous non-small cell lung cancer: A double-blind, randomized, placebo-controlled study
    Dong, Xiaorong
    Huang, Yu
    Yi, Tienan
    Hu, Chunhong
    Gao, Quanli
    Chen, Yuan
    Zhang, Jing
    Chen, Jianhua
    Liu, Li
    Meng, Rui
    Zhang, Sheng
    Dai, Xiaofang
    Fei, Shihong
    Jin, Yang
    Yin, Ping
    Hu, Yanping
    Wu, Gang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
123